查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1803020

全球 SPECT 掃描服務市場：預測至 2032 年 - 按產品類型、放射性同位素類型、應用、最終用戶和地區進行分析

SPECT Scanning Services Market Forecasts to 2032 - Global Analysis By Product Type, Radioisotope Type (Technetium-99m, Gallium-67, Iodine-123, Thallium-201, Radium-223 and Other Radioisotope Types), Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，全球 SPECT 掃描服務市場預計在 2025 年達到 27.5 億美元，到 2032 年將達到 54.7 億美元，預測期內的複合年成長率為 10.3%。

SPECT掃描服務利用單光子發射電腦斷層掃描（SEP）技術，透過偵測放射性示蹤劑發射的伽瑪射線，創造內臟器官和組織的詳細3D影像。這些服務透過評估血流、代謝活動和受體結合情況，支持神經系統、心臟和腫瘤疾病的診斷評估。此操作為非侵入式，通常在專門的影像中心進行。核子醫學專家的精準判讀有助於早期發現疾病、制定治療計劃並監測治療效果，從而改善臨床決策和患者預後。

根據《EJNMMI Physics》報道，SPECT 影像已成為核子醫學應用的基石，全球超過 70% 的核子醫學部門整合了 SPECT 或 SPECT/CT 系統，用於心臟病學、神經病學和腫瘤學的常規診斷和治療計劃。

心血管、腫瘤、神經和代謝疾病發生率上升

隨著這些慢性疾病在人群中日益普遍，醫療保健提供者越來越依賴先進的影像技術進行早期發現和精準監測。此外，SPECT 技術效率和準確性的不斷提升也推動了其在臨床上的應用，並改善了患者的預後。個人化醫療日益受到重視，這進一步推動了 SPECT 檢測的使用，使其能夠根據患者的個別情況量身定做治療方案。

來自PET和其他治療方式的競爭壓力

PET 尤其成為腫瘤學和神經病學領域的首選，因為它具有卓越的空間解析度和定量分析能力。此外，PET/CT 和 PET/MRI 等混合影像系統也因其能夠整合解剖和功能資料而日益普及。這種競爭格局要求 SPECT服務供應商不斷創新，提升影像品質、工作流程效率和示蹤劑特異性，才能在快速發展的診斷生態系統中保持競爭力。

與人工智慧（AI）和機器學習的整合

人工智慧和機器學習與 SPECT 影像工作流程的整合，為市場成長帶來了變革性機會。這些技術正被用於增強影像重建、自動化異常檢測和最佳化掃描通訊協定，從而提高診斷準確性和業務效率。主導的分析也有助於預測建模和個人化治療計劃，從而提升 SPECT 在精準醫療中的價值。

依賴訓練有素的核子醫學和放射學專業人員

準確解讀 SPECT 掃描結果需要大量的核子醫學和放射學培訓，這限制了在勞動力短缺地區開展服務的擴充性。此外，放射性藥物的處理和合規性非常複雜，需要嚴格的監管，並可能造成營運資源緊張。如果教育和培訓投入不足，合格專業人員的缺乏可能會阻礙服務擴展，並延遲在服務匱乏地區的推廣。

COVID-19的影響：

新冠疫情對 SPECT 掃描服務市場產生了多方面的影響。起初，由於封鎖和感染控制措施，選擇性影像檢查被推遲，患者數量也隨之減少。然而，這場危機也凸顯了影像學在管理與病毒相關的心血管和肺部併發症的重要性。隨著醫療系統適應疫情，SPECT 服務的優先順序被重新調整，用於重症加護和新冠疫情後評估。

預計 SPECT 掃描設備市場在預測期內將佔據最大佔有率

由於 SPECT 掃描設備在臨床上的廣泛應用和技術進步，預計將在預測期內佔據最大的市場佔有率。這些系統擴大配備了多檢測器配置和數位處理功能，從而提高了影像解析度和吞吐量。它們能夠診斷從心臟缺血到神經退化性疾病等一系列疾病，使其成為功能性影像診斷的基石。

冠狀動脈疾病診斷領域預計將在預測期內實現最高複合年成長率

冠狀動脈疾病診斷領域預計將在預測期內實現最高成長率，這得益於全球心血管疾病負擔的不斷增加。 SPECT心肌灌注顯像是一種成熟的技術，可用於評估血流和偵測缺血區域，為了解心臟功能提供重要依據。放射性示蹤劑和影像通訊協定的創新正在提高診斷準確性和病患安全性。隨著預防心臟病學的發展勢頭強勁，SPECT在風險分層和治療效果監測方面發揮關鍵作用，尤其是在高風險族群中。

佔比最高的地區：

預計北美將在預測期內佔據最大的市場佔有率，這得益於其先進的醫療基礎設施和核醫學成像技術的廣泛應用。該地區擁有許多優勢，例如強大的報銷框架、主要成像設備製造商的佈局以及訓練有素的專業人員的廣泛供應。此外，正在進行的研究舉措和臨床試驗正在推動放射性藥物和成像通訊協定的創新。

複合年成長率最高的地區：

預計北美將在預測期內實現最高的複合年成長率，這得益於醫療基礎設施的擴張、人們對先進影像診斷技術的認知不斷提高，以及中國和印度等新興經濟體心血管和神經系統疾病等慢性病患病率的上升。此外，政府旨在改善醫療服務可近性的措施、增加醫療技術投入以及可支配收入的提高，正在刺激 SPECT 掃描服務的普及。

免費客製化服務

此報告的訂閱者可以從以下免費自訂選項中選擇一項：

  • 公司簡介
    • 對最多三家其他公司進行全面分析
    • 主要企業的SWOT分析（最多3家公司）
  • 區域分類
    • 根據客戶興趣對主要國家進行的市場估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第 2 章 簡介

  • 概述
  • 相關利益者
  • 分析範圍
  • 分析方法
    • 資料探勘
    • 數據分析
    • 數據檢驗
    • 分析方法
  • 分析材料
    • 主要研究資料
    • 二手研究資訊來源
    • 先決條件

第3章市場走勢分析

  • 驅動程式
  • 抑制因素
  • 市場機會
  • 威脅
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • COVID-19的感染疾病

第4章 波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代產品的威脅
  • 新參與企業的威脅
  • 企業之間的競爭

5.全球SPECT 掃描服務市場（依產品類型）

  • SPECT掃描設備
    • 可攜式SPECT 系統
    • 固定/獨立 SPECT 系統
    • SPECT/CT混合系統
  • SPECT掃描服務
    • 診斷影像
    • 治療監測
    • 藥物開發和研究支持

6.全球SPECT 掃描服務市場（依放射性同位素類型）

  • Technetium-99m（Tc-99m）
  • 鎵-67（Ga-67）
  • 碘-123（I-123）
  • 鉈-201（Th-201）
  • 鐳-223（Ra-223）
  • 其他類型的放射性同位素

7.全球SPECT 掃描服務市場（按應用）

  • 心肌灌注顯像
  • 冠狀動脈疾病的診斷
  • 腫瘤檢測與監測
  • 癌症分期
  • 腦損傷
  • 癲癇診斷
  • 其他用途

8.全球SPECT 掃描服務市場（按最終用戶）

  • 診斷影像中心
  • 醫院
  • 門診手術中心（ASC）
  • 研究和學術機構
  • 其他最終用戶

9.全球SPECT 掃描服務市場（按地區）

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲地區

第10章：主要趨勢

  • 合約、商業夥伴關係和合資企業
  • 企業合併與收購（M&A）
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第11章 公司概況

  • GE Healthcare
  • Siemens Healthineers
  • Philips Healthcare
  • Bracco Imaging
  • Curium Pharma
  • Cardinal Health Inc.
  • Lantheus Medical Imaging
  • Digirad Corporation
  • Spectrum Dynamics Medical
  • Gamma Medica Inc.
  • Guerbet
  • Neusoft Medical Systems
  • Toshiba International Corporation
  • Mediso Ltd.
  • Positron Corporation
Product Code: SMRC30546

According to Stratistics MRC, the Global SPECT Scanning Services Market is accounted for $2.75 billion in 2025 and is expected to reach $5.47 billion by 2032 growing at a CAGR of 10.3% during the forecast period. SPECT scanning services utilize Single Photon Emission Computed Tomography to produce detailed 3D images of internal organs and tissues by detecting gamma rays emitted from radiotracers. These services support diagnostic evaluation of neurological, cardiac, and oncological conditions by assessing blood flow, metabolic activity, and receptor binding. Procedures are non-invasive and typically conducted in specialized imaging centers. Accurate interpretation by nuclear medicine professionals enables early disease detection, treatment planning, and monitoring of therapeutic response, enhancing clinical decision-making and patient care outcomes.

According to EJNMMI Physics, SPECT imaging has become a cornerstone in theranostic applications, with over 70% of nuclear medicine department's worldwide integrating SPECT or SPECT/CT systems for routine diagnostic and therapeutic planning in cardiology, neurology, and oncology.

Market Dynamics:

Driver:

Increased rates of cardiovascular, oncological, neurological, and metabolic disorders

As these chronic diseases become more prevalent across demographics, healthcare providers increasingly rely on advanced diagnostic imaging to enable early detection and accurate monitoring. Additionally, improvements in the efficiency and precision of SPECT technology are encouraging wider clinical adoption, supporting better patient outcomes. The growing emphasis on personalized medicine further drives the use of SPECT scans to tailor treatments based on individual patient profiles.

Restraint:

Competitive pressure from PET and other modalities

PET, in particular, offers superior spatial resolution and quantitative capabilities, making it the preferred choice in oncology and neurology. Additionally, hybrid imaging systems like PET/CT and PET/MRI are gaining traction due to their ability to combine anatomical and functional data. This competitive landscape is challenging SPECT service providers to innovate and improve image quality, workflow efficiency, and tracer specificity to maintain relevance in a rapidly evolving diagnostic ecosystem.

Opportunity:

Integration with artificial intelligence (AI) and machine learning

The integration of AI and machine learning into SPECT imaging workflows presents a transformative opportunity for market growth. These technologies are being leveraged to enhance image reconstruction, automate anomaly detection, and optimize scan protocols, thereby improving diagnostic accuracy and operational efficiency. AI-driven analytics can also assist in predictive modeling and personalized treatment planning, making SPECT more valuable in precision medicine.

Threat:

Reliance on highly trained nuclear medicine and radiology professionals

Accurate interpretation of SPECT scans requires extensive training in nuclear medicine and radiology, limiting the scalability of services in regions with workforce shortages. Additionally, the complexity of radiopharmaceutical handling and regulatory compliance demands rigorous oversight, which can strain operational resources. Without sufficient investment in education and training, the shortage of qualified professionals may hinder service expansion and delay adoption in underserved areas.

Covid-19 Impact:

The COVID-19 pandemic had a multifaceted impact on the SPECT scanning services market. Initially, elective imaging procedures were postponed, and patient volumes declined due to lockdowns and infection control measures. However, the crisis also highlighted the importance of diagnostic imaging in managing cardiovascular and pulmonary complications associated with the virus. As healthcare systems adapted to the pandemic, SPECT services were re-prioritized for critical care and post-COVID evaluations.

The SPECT scanning devices segment is expected to be the largest during the forecast period

The SPECT scanning devices segment is expected to account for the largest market share during the forecast period due to their widespread clinical adoption and technological advancements. These systems are increasingly being equipped with multi-detector configurations and digital processing capabilities, enhancing image resolution and throughput. Their versatility in diagnosing a range of conditions from cardiac ischemia to neurodegenerative disorders makes them a cornerstone of functional imaging.

The coronary artery disease diagnosis segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the coronary artery disease diagnosis segment is predicted to witness the highest growth rate driven by the escalating burden of cardiovascular conditions worldwide. SPECT myocardial perfusion imaging is a well-established technique for assessing blood flow and detecting ischemic regions, offering critical insights into cardiac function. Innovations in radiotracers and imaging protocols are improving diagnostic precision and patient safety. As preventive cardiology gains momentum, SPECT is playing a vital role in risk stratification and monitoring therapeutic efficacy, especially in high-risk populations.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share attributed to its advanced healthcare infrastructure and high adoption of nuclear imaging technologies. The region benefits from a robust reimbursement framework, strong presence of leading imaging equipment manufacturers, and widespread availability of trained professionals. Additionally, ongoing research initiatives and clinical trials are fostering innovation in radiopharmaceuticals and imaging protocols.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR owing to rapid growth is driven by expanding healthcare infrastructure, increasing awareness of advanced diagnostic imaging, and rising prevalence of chronic diseases such as cardiovascular and neurological disorders in emerging economies like China and India. Additionally, government initiatives aimed at improving healthcare access, coupled with growing investments in medical technology and rising disposable incomes, are fueling the adoption of SPECT scanning services.

Key players in the market

Some of the key players in SPECT Scanning Services Market include GE Healthcare, Siemens Healthineers, Philips Healthcare, Bracco Imaging, Curium Pharma, Cardinal Health Inc., Lantheus Medical Imaging, Digirad Corporation, Spectrum Dynamics Medical, Gamma Medica Inc., Guerbet, Neusoft Medical Systems, Toshiba International Corporation, Mediso Ltd. and Positron Corporation.

Key Developments:

In August 2025, Cardinal Health acquired Solaris Health, a leading urology MSO. The move supports specialty care expansion and aligns with strong Q4 earnings of $60.2B revenue.

In January 2025, Philips showcased AI-driven diagnostic and monitoring systems at Arab Health 2025. Highlights included the BlueSeal helium-free MRI and Spectral CT 7500 for advanced imaging.

In January 2025, Siemens Healthineers unveiled photon-counting CT and helium-free MRI at Arab Health 2025. The NAEOTOM Alpha and MAGNETOM Flow platforms aim to redefine precision imaging and sustainability.

Product Types Covered:

  • SPECT Scanning Devices
  • SPECT Scanning Services

Radioisotope Types Covered:

  • Technetium-99m (Tc-99m)
  • Gallium-67 (Ga-67)
  • Iodine-123 (I-123)
  • Thallium-201 (Th-201)
  • Radium-223 (Ra-223)
  • Other Radioisotope Types

Applications Covered:

  • Myocardial Perfusion Imaging
  • Coronary Artery Disease Diagnosis
  • Tumor Detection & Monitoring
  • Cancer Staging
  • Brain Disorders
  • Epilepsy Diagnosis
  • Other Applications

End Users Covered:

  • Diagnostic Imaging Centers
  • Hospitals
  • Ambulatory Surgical Centers (ASCs)
  • Research & Academic Institutes
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global SPECT Scanning Services Market, By Product Type

  • 5.1 Introduction
  • 5.2 SPECT Scanning Devices
    • 5.2.1 Portable SPECT Systems
    • 5.2.2 Fixed/Standalone SPECT Systems
    • 5.2.3 SPECT/CT Hybrid Systems
  • 5.3 SPECT Scanning Services
    • 5.3.1 Diagnostic Imaging
    • 5.3.2 Therapeutic Monitoring
    • 5.3.3 Drug Development & Research Support

6 Global SPECT Scanning Services Market, By Radioisotope Type

  • 6.1 Introduction
  • 6.2 Technetium-99m (Tc-99m)
  • 6.3 Gallium-67 (Ga-67)
  • 6.4 Iodine-123 (I-123)
  • 6.5 Thallium-201 (Th-201)
  • 6.6 Radium-223 (Ra-223)
  • 6.7 Other Radioisotope Types

7 Global SPECT Scanning Services Market, By Application

  • 7.1 Introduction
  • 7.2 Myocardial Perfusion Imaging
  • 7.3 Coronary Artery Disease Diagnosis
  • 7.4 Tumor Detection & Monitoring
  • 7.5 Cancer Staging
  • 7.6 Brain Disorders
  • 7.7 Epilepsy Diagnosis
  • 7.8 Other Applications

8 Global SPECT Scanning Services Market, By End User

  • 8.1 Introduction
  • 8.2 Diagnostic Imaging Centers
  • 8.3 Hospitals
  • 8.4 Ambulatory Surgical Centers (ASCs)
  • 8.5 Research & Academic Institutes
  • 8.6 Other End Users

9 Global SPECT Scanning Services Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 GE Healthcare
  • 11.2 Siemens Healthineers
  • 11.3 Philips Healthcare
  • 11.4 Bracco Imaging
  • 11.5 Curium Pharma
  • 11.6 Cardinal Health Inc.
  • 11.7 Lantheus Medical Imaging
  • 11.8 Digirad Corporation
  • 11.9 Spectrum Dynamics Medical
  • 11.10 Gamma Medica Inc.
  • 11.11 Guerbet
  • 11.12 Neusoft Medical Systems
  • 11.13 Toshiba International Corporation
  • 11.14 Mediso Ltd.
  • 11.15 Positron Corporation

List of Tables

able 1 Global SPECT Scanning Services Market Outlook, By Region (2024-2032) ($MN)

  • Table 2 Global SPECT Scanning Services Market Outlook, By Product Type (2024-2032) ($MN)
  • Table 3 Global SPECT Scanning Services Market Outlook, By SPECT Scanning Devices (2024-2032) ($MN)
  • Table 4 Global SPECT Scanning Services Market Outlook, By Portable SPECT Systems (2024-2032) ($MN)
  • Table 5 Global SPECT Scanning Services Market Outlook, By Fixed/Standalone SPECT Systems (2024-2032) ($MN)
  • Table 6 Global SPECT Scanning Services Market Outlook, By SPECT/CT Hybrid Systems (2024-2032) ($MN)
  • Table 7 Global SPECT Scanning Services Market Outlook, By SPECT Scanning Services (2024-2032) ($MN)
  • Table 8 Global SPECT Scanning Services Market Outlook, By Diagnostic Imaging (2024-2032) ($MN)
  • Table 9 Global SPECT Scanning Services Market Outlook, By Therapeutic Monitoring (2024-2032) ($MN)
  • Table 10 Global SPECT Scanning Services Market Outlook, By Drug Development & Research Support (2024-2032) ($MN)
  • Table 11 Global SPECT Scanning Services Market Outlook, By Radioisotope Type (2024-2032) ($MN)
  • Table 12 Global SPECT Scanning Services Market Outlook, By Technetium-99m (Tc-99m) (2024-2032) ($MN)
  • Table 13 Global SPECT Scanning Services Market Outlook, By Gallium-67 (Ga-67) (2024-2032) ($MN)
  • Table 14 Global SPECT Scanning Services Market Outlook, By Iodine-123 (I-123) (2024-2032) ($MN)
  • Table 15 Global SPECT Scanning Services Market Outlook, By Thallium-201 (Th-201) (2024-2032) ($MN)
  • Table 16 Global SPECT Scanning Services Market Outlook, By Radium-223 (Ra-223) (2024-2032) ($MN)
  • Table 17 Global SPECT Scanning Services Market Outlook, By Other Radioisotope Types (2024-2032) ($MN)
  • Table 18 Global SPECT Scanning Services Market Outlook, By Application (2024-2032) ($MN)
  • Table 19 Global SPECT Scanning Services Market Outlook, By Myocardial Perfusion Imaging (2024-2032) ($MN)
  • Table 20 Global SPECT Scanning Services Market Outlook, By Coronary Artery Disease Diagnosis (2024-2032) ($MN)
  • Table 21 Global SPECT Scanning Services Market Outlook, By Tumor Detection & Monitoring (2024-2032) ($MN)
  • Table 22 Global SPECT Scanning Services Market Outlook, By Cancer Staging (2024-2032) ($MN)
  • Table 23 Global SPECT Scanning Services Market Outlook, By Brain Disorders (2024-2032) ($MN)
  • Table 24 Global SPECT Scanning Services Market Outlook, By Epilepsy Diagnosis (2024-2032) ($MN)
  • Table 25 Global SPECT Scanning Services Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 26 Global SPECT Scanning Services Market Outlook, By End User (2024-2032) ($MN)
  • Table 27 Global SPECT Scanning Services Market Outlook, By Diagnostic Imaging Centers (2024-2032) ($MN)
  • Table 28 Global SPECT Scanning Services Market Outlook, By Hospitals (2024-2032) ($MN)
  • Table 29 Global SPECT Scanning Services Market Outlook, By Ambulatory Surgical Centers (ASCs) (2024-2032) ($MN)
  • Table 30 Global SPECT Scanning Services Market Outlook, By Research & Academic Institutes (2024-2032) ($MN)
  • Table 31 Global SPECT Scanning Services Market Outlook, By Other End Users (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.